Medicinal Product Shortages - update - 17 August 2022

Notice type: Advisory

Date: 17/08/2022


Further Information:

 The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Acerycal 10mg/10mg tablets - PA0568/018/004
  • Apidra Solostar 100units/ml Solution for Injection in a Pre-Filled Pen - EU/1/04/285/032
  • Creon 10000 Gastro Resistant Capsules - PA2010/008/003
  • Creon 25000 Gastro Resistant Capsules - PA2010/008/002
  • Fucidin 20mg/g Cream - PA0046/004/012
  • Lyrica 75mg Hard Capsules - EU/1/04/279/012
  • Nasofan Aqueous 50mcg Nasal Spray Suspension - PA1986/084/001
  • Pregabalin Sandoz 50mg Tablets - EU/1/15/1011/013
  • Pregabalin Sandoz 75mg Tablets - EU/1/15/1011/021
  • Pregabalin Sandoz 150mg Tablets - EU/1/15/1011/045
  • Rifater 50mg/300 mg/120 mg Tablets - PA0540/067/001
  • Rivotril 0.5mg Tablets - PA2239/020/001
  • Skinoren 15% Gel - PA1025/009/001
  • Somavert 15mg Powder and Solvent for Solution for Injection - EU/1/02/240/002
  • Stemetil 12.5mg/ml Solution for Injection - PA0540/127/002
  • Symbicort Turbohaler 200mcg/6mcg, Inhalation Powder - PPA1463/051/001
  • Toviaz 8mg Prolonged Release Tablets - EU/1/07/386/008


The following shortages have been resolved and supply has resumed to the Irish market:

  • Cytarabine 20mg/ml Solution for Injection or Infusion - PA0822/200/001
  • Epilim Intravenous 400mg Powder and Solvent for Solution for Injection or Infusion - PA0540/150/013
  • Hypnovel 10mg/2ml Solution for Injection - PA2239/007/001
  • Proscar 5mg Film Coated Tablets - PA23198/007/001
  • Toujeo SoloStar 300 units/ml Solution for Injection in a Pre Filled Pen - EU/1/00/133/035
  • Toviaz 4mg Prolonged Release Tablets - EU/1/07/386/003
  • Zofran Zydis 4mg Oral Lyophilisate - PA0896/036/007
  • Zofran Zydis 8mg Oral Lyophilisate - PA0896/036/008
  • Zostavax Powder and Solvent for Suspension for Injection in a Pre-Filled Syringe - EU/1/06/341/011


Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

« Back